It is important to note that enzyme activity and biochemical binding assays, as well as Western blots of acetylated HDAC substrates, indicate the molecular interaction between a compound and an HDAC enzyme, while proliferation assays and in vivo xenograft tumor models demonstrate the intended biological outcome of HDAC inhibition. Here, HDAC9 is linked to neoplasm.